BioCentury
ARTICLE | Clinical News

Novogen preclinical data

March 31, 2014 7:00 AM UTC

In a mouse xenograft model of ovarian cancer, Trx-1 significantly reduced tumor growth. Last November, Novogen and Yale University (New Haven, Conn.) formed a JV, CanTx Inc. (New Haven, Conn.), to de...